HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kathrin Rychli Selected Research

Heart Failure

12/2012Fractalkine is an independent predictor of mortality in patients with advanced heart failure.
7/2011Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.
12/2010Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure.
9/2010Prognostic value of pigment epithelium-derived factor in patients with advanced heart failure.
11/2009Pigment epithelium-derived factor (PEDF) as a therapeutic target in cardiovascular disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kathrin Rychli Research Topics

Disease

5Heart Failure
12/2012 - 11/2009
2Inflammation (Inflammations)
04/2017 - 03/2011
2Cardiovascular Diseases (Cardiovascular Disease)
03/2011 - 11/2009
2Hypoxia (Hypoxemia)
01/2010 - 06/2006
2Myocardial Infarction
11/2009 - 06/2006
2Coronary Disease (Coronary Heart Disease)
11/2009 - 09/2007
2Necrosis
11/2009 - 04/2009
1Listeriosis (Listeria Infection)
11/2020
1Bovine Mastitis
01/2018
1Infections
01/2015
1Atherosclerotic Plaque (Atheroma)
09/2011
1Pathologic Neovascularization
03/2011
1Ventricular Dysfunction
11/2009
1Atherosclerosis
11/2009
1Fibrosis (Cirrhosis)
11/2009
1Neointima
09/2007
1Thrombosis (Thrombus)
09/2007
1Neoplasms (Cancer)
10/2006

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
03/2011 - 06/2006
2LigandsIBA
03/2011 - 04/2009
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2011 - 10/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2010 - 11/2009
2pigment epithelium-derived factorIBA
09/2010 - 11/2009
1Clonidine (ST 155)FDA LinkGeneric
11/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2018
1Local Anti-Infective Agents (Antiseptics)IBA
01/2018
12,3-dihydroxybenzaldehydeIBA
01/2018
1Butyrates (Butyrate)IBA
04/2017
1Fatty Acids (Saturated Fatty Acids)IBA
04/2017
1Virulence Factors (Pathogenicity Factors)IBA
01/2015
1Chemokine CX3CL1IBA
12/2012
1Interleukin-33IBA
09/2011
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2011
1SelectinsIBA
09/2011
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
09/2011
1Proteins (Proteins, Gene)FDA Link
09/2011
1Messenger RNA (mRNA)IBA
09/2011
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2011
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
07/2011
12- phenyl- 5,5- dimethyltetrahydro- 1,4- oxazineIBA
03/2011
1Glycoproteins (Glycoprotein)IBA
03/2011
1Oncostatin MIBA
03/2011
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2010
12,2'-Dipyridyl (2,2 Bipyridine)IBA
01/2010
1cobaltous chloride (cobalt(II)chloride)IBA
01/2010
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2010
1FluvastatinFDA Link
11/2009
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2009
1AntioxidantsIBA
11/2009
1Interleukin-1alpha (Interleukin 1 alpha)IBA
11/2009
1Transforming Growth Factor beta (TGF-beta)IBA
11/2009
1Plasminogen Activator Inhibitor 1IBA
09/2007
1Monocyte Chemoattractant ProteinsIBA
06/2006
1ChemokinesIBA
06/2006